Handelsavisen
prelaunch
Companies ›Consumer Non Cyclicals ›0775.HK
07
0775.HK — HKEX Food Processing

CK Life Sciences Intl (Holdings) Inc

HK$0,70
Open in Charts → Attach watcher ⌖
— —
HKD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
—
P/E
—
EV / Rev
—
Div yield
0,00 %
Op margin
4,6 %
ROE
-4,9 %
Net margin
-3,5 %
Debt / equity
1,75
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
—
Open
—
Next earnings
—
Ex-dividend
—
TR 1Y
—
About

CK Life Sciences Intl (Holdings) Inc operates in the Food Processing industry, primarily generating revenue through the production and sale of food products.

Business. CK Life Sciences Intl (Holdings) Inc (0775.HK) is a food processing company operating within the Consumer Non-Cyclicals sector. The firm generates revenue through product sales in the Food & Beverages industry. Specific details regarding its operating segments and geographic presence are not disclosed. The company is primarily listed on the Hong Kong Stock Exchange.

Classification92 %
SectorConsumer Non-Cyclicals
Business sectorFood & Beverages
IndustryFood Processing
Generated · model-assisted
Sell-side consensus
—consensus pending
— buy— hold— sell
Avg 12m price target—
Upcoming events
— missing data
See all catalysts →

At a glance

Score
—
not yet scored
Valuation
—
valuation pending
Analysts
—
not yet wired
Ownership
—
not yet wired
Profitability→
-4,9 %
return on equity
Quality
—
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 0775.

    • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples · THIS SECTOR−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 0775.HK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    CK Life Sciences Intl (Holdings) Inc (0775.HK) is a food processing company operating within the Consumer Non-Cyclicals sector. The firm generates revenue through product sales in the Food & Beverages industry. Specific details regarding its operating segments and geographic presence are not disclosed. The company is primarily listed on the Hong Kong Stock Exchange.

    Classification92 %
    SectorConsumer Non-Cyclicals
    Business sectorFood & Beverages
    IndustryFood Processing
    AI synthesis
    GENERATED

    CK Life Sciences Intl (Holdings) Inc has a debt-to-equity ratio of 1.75, indicating a relatively high level of leverage. The company's liquidity is assessed as medium, with a current ratio of 0.87, suggesting potential challenges in meeting short-term obligations. The return on equity is -4.94%, and the return on assets is -1.58%, both significantly below the industry median for profitability metrics.

    The company's operating income of HKD 248.5 million is modest compared to the industry median, and the net loss of HKD 186.8 million indicates poor profitability. The company's gross profit margin is 29.15%, which is below the industry median, further highlighting its cost inefficiencies.

    CK Life Sciences Intl (Holdings) Inc's revenue is primarily concentrated in a few segments, with no detailed breakdown provided in the available data. The company's geographic exposure is not specified, but the lack of diversification could pose a risk to its revenue stability.

    The company's revenue growth is expected to remain flat in the current fiscal year, with no significant improvement projected for the next fiscal year. The negative net income and high debt levels suggest a challenging growth trajectory.

    The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key financial flag is the negative net cash position after subtracting total debt, which could impact its ability to fund operations and investments. No recent events or filings have been disclosed that would significantly affect the company's financial position.

    Key takeaways
    • The company has a high debt-to-equity ratio, indicating significant leverage.
    • The company is currently reporting a net loss, which is a concern for profitability.
    • The company's liquidity position is medium, with a current ratio below 1.
    • The company's return on equity and return on assets are negative, suggesting poor asset utilization and profitability.
    • The company's growth trajectory is expected to be flat, with no significant improvement in the near term.
    • "margin_outlook_rationale": "The company's gross profit margin is below the industry median, indicating potential cost inefficiencies.",

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    HK$0,70
    Market cap
    —
    Enterprise valueⓘ
    —
    P/Eⓘ
    —
    Non-GAAP P/Eⓘ
    —
    EV / Revenueⓘ
    —
    EV / Op incomeⓘ
    —
    EV / OCFⓘ
    —
    P / Bⓘ
    —
    P / Tangible bookⓘ
    —
    Tangible book
    HK$3.78B
    Net cashⓘ
    -HK$6.62B
    Current ratioⓘ
    0.9
    Debt / equityⓘ
    1.8
    ROAⓘ
    -1.6%
    ROEⓘ
    -4.9%
    Cash conversionⓘ
    -100.0%
    CapEx / revenueⓘ
    -4.6%
    SBC / revenueⓘ
    —
    Dilution ratioⓘ
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin4,6 %Below median
    Net Margin-3,5 %Bottom quartile
    ROE-4,9 %Bottom quartile
    Capex / Rev-4,6 %Below median
    D/E1,75Bottom quartile
    Cash Conv-1,00Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • CK Life Sciences Intl (Holdings) Inc Market data — financials · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    0775.HKCanonical
    HKEX · HKD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage